511 days ago
I start by mentioning tomorrow’s activities. many, many thanks to the 300+ folks who have donated. If I have not reminded you enough and you have forgotten to sponsor the rogue bloggers for Woodlarks there is still time HERE. Then I mention a knobhead called Robbie. Then it is onto Odey share overhangs, mentioning Shanta (SHG) en passant, IOG (IOG), Wray and Alliance Pharma (APH) in days gone by, Canadian Overseas Petroleum Limited (COPL) and finally two minnows on the brink of going under, I suspect: Deepverge (DVRG) and Microsaic (MSYS).
729 days ago
I start with a few words on Jubilee Metals (JLP) and Bluebird Merchant Ventures (BMV). Then some Trustpilot detective work on AQRU (AQRU) which, I predict, will go bust in 2023. I move on to Xtract Resources (XTR), Shearwater (SWG), Alliance Pharma (APH) and then to the impending demise of Applied Graphene Materials (AGM). Gotcha! I also cover Argo Blockchain (ARB) which I still have down as a 2022 bust, maybe as soon as this week
2390 days ago
This is, of course, a big fave of Nigel Wray and he has done exceptionally well from Alliance Pharma (APH). It has also been a good share tip (twice) from myself and young Steve on the Nifty Fifty. The main man is John Dawson and he can explain the story going forward.
2548 days ago
Alliance Pharma (APH) has announced a $7.5 million acquisition from medical technology company Smith & Nephew, with CEO John Dawson emphasising “the acquisition will be immediately earnings enhancing, accretive to our underlying return on invested capital, and it fits well in our existing bedrock business operations”…
2682 days ago
Alliance Pharma (APH) has updated on trading for the first half of 2017, ahead of a results announcement expected on 13th September…
2735 days ago
Alliance Pharma (APH) has made an AGM update announcement, including that trading “is good and in line with the board's expectations” and that “cash flow in the business remains strong”. This is a healthy reaffirmation of our BUY tip of last month which is now well in the money.
2775 days ago
Specialty pharmaceutical company, Alliance Pharma (APH) is a previous successful share tip for us - recommended at 31p, with gains banked at 43p in 2015. However, there has since been positive development which looks inadequately reflected in a current sub 50p offer price and, noting also the continued presence of famed investors Nigel Wray and Slater Investments as major shareholders…
3110 days ago
Alliance Pharma (APH) has, relatively, recently completed a transformational acquisition. I know that Nigel Wray remains a big fan as does Mark Slater. Sensible value investors should thus find the presentation by John Dawson of interest
3286 days ago
Oh no Paul Scott is giving me health advice again. If he promises never ever to waterboard me again with online retail gross margins I might just quit smoking. Away from that I look at car crash Slater & Gordon (SGH) following up from the earlier detailed piece HERE. In a similar vein I look at NAHL (NAH). Then it is onto EKF Diagnostics (EKF), Moneyswap (SWAP), Oilex (OEX), Forte Energy (FTE), Alliance Pharma (APH), Iofina (IOF) and the Fitbug (FITB) dog. There is no mention of Jabba The Hutt today, David Lenigas must wait for Gold & Bears on Saturday for his next drubbing. And boy will it be a drubbing.
3465 days ago
Alliance Pharma (APH) has updated investors that “trading in the first four months of 2015 has been satisfactory” and that“we look forward to the remainder of 2015 with confidence.”
3487 days ago
Amiong those presenting in the healthcare and biotech master class were John Dawson of Alliance Pharma, Steve Moore, Adam Reynolds of Premaitha and Optibiotix, Venn Life and Collagen. Enjoy
3505 days ago
Alliance Pharma (APH) is a stock that Britain’s Buffett had held for ten years and it is also a great sleep-sound core portfolio buy for me. Its CEO John Dawson is a good man and I like the company. Anyhow he, and the CEOs of Rex Bionics, Accesso and Akers Biosciences, of which I know sweet FA are presenting in London at the Proactive forum this Thursday 23rd). There’s free food & booze on offer as well. And
3530 days ago
Speciality pharmaceuticals company Alliance Pharma (APH) has announced results for the 2014 calendar year and that “we enter 2015 well placed for resumed growth”. That is not discounted in the current share price.
3596 days ago
Speciality pharmaceutical company, Alliance Pharma (APH) has updated that 2014 “pre-tax profits are expected to be in line with current market expectations” on turnover of £43.5 million and that “we continue to evaluate a number of acquisition opportunities”.
3724 days ago
Alliance Pharma (APH) last week announced results for the first half of the 2014 calendar year and that “we expect full year results to be in line with market expectations”. This makes the shares a buy at up to 35p
3837 days ago
Alliance Pharma (APH) has updated investors attending its AGM that “trading in the first four months of 2014 has been in line with expectations” and that “we continue to work towards delivering further earnings enhancing acquisitions to outperform those plans”.
3961 days ago
Speciality pharmaceutical company, Alliance Pharma (APH) last week announced that “turnover for 2013 is expected to be £45.5m (2012: £44.9m) and pre-tax profits are expected to be in line with current market expectations” (expectations are for earnings per share of around 3.5p) as well as an acquisition of the rights to the thyroid product Irenat in Germany from subsidiaries of Bayer AG.
In the 12 months to October 2013, total sales of Irenat by Bayer were €0.8 million and the gross margin generated was €0.5 million – with the company emphasising that “the acquisition, our first in Germany, will be immediately earnings enhancing and fits well with our strategy of building Alliance's international sales”. No acquisition price was provided though house broker, Numis, estimates £1.2 million.
Also positively,
4047 days ago
There are now just 15 golden tickets left for the UK Investor Show on April 5th while normal tickets are selling fast - why?
The speaker line-up gets stronger by the week. This week FT & IC Columnist Dominic Picarda became our latest big name recruit. Dominic will chair one of the main stage sessions and will do a 100 person breakout room session on how to use ETFs to create a growth portfolio.
There are a maximum of 100 seats for any breakout session. Gold ticket holders get to reserve a seat at whatever main stage or breakout session they wish in advance.
We are also delighted to announce that spreadbetting form ETX has become a main sponsor of the show while three more PLCs - Amara Mining, Falanx and Viscount Minerals (a new silver play from legendary Kaare Foy) have come on board to man a stand and give 20 minute breakout presentations on the day.
Book NOW to ensure you get your spot
All of that goes to show once again...
There is only one investor show worth attending if you want to hear an array of big name speakers in sparky debate and meet dozens of growth companies. And this year the UK Investor Show has a new venue, the Queen Elizabeth centre in central London.
The date for your diary is 5 April 2014
More than 25 big name speakers are already signed up to appear including Britain’s Buffett Nigel Wray, legendary Terry Smith bear raiders Matt Earl and Lucian Miers, gold gurus Amanda Van Dyke and Dominic Frisby, Ed Croft of Stockopedia, Dominic Picarda, John Walsh, Alpesh Patel, Richard Poulden, David Lenigas, controversial mining analyst turned entrepreneur Matt Sutcliffe, infamous bloggers Brokerman Daniel and Doc Holiday, Clem Chambers, Tom Winnifrith and Roger Lawson.
The full list of speakers grows by the day and can be found here
As ever Britain’s most interesting small cap companies will also not only be manning stands but also each giving a 20 minute presentation. Six months ahead of the show more than FIFTY companies are already booked into attend at CEO level including Alliance Pharma, Stanley Gibbons, EMED, Leyshon Resources, 1Spatial, Amara Mining, Falanx, Leni Gas & Oil, Nostra Terra and many more.
You can find the list of those companies already booked in to attend here.
This year there are two classes of tickets.
An entrance pass costs £10 + VAT and gives entrance to the show and to all speaker sessions (subject to seating availability).
A Golden ticket costs £50 + VAT. There were just 75 available. A golden ticket gives you the right to reserve a front seat at any one of the 80 sessions running throughout the day. It also entitles you to come along to a champagne reception with a number of the keynote speakers and presenting CEOs afterwards with transport to the venue arranged.
THERE ARE NOW JUST 15 GOLDEN TICKETS LEFT!
Book NOW to ensure you get your spot
As each day goes by we will add more speakers and companies to those attending. We do not just claim to have companies attending unlike some also ran events, we name them. To keep updated on out growing roster of star speakers and growth companies presenting follow us on Twitter @ukinvestorshow
Book NOW to ensure you get your spot
On behalf of ADVFN and myself, the joint organisers of this show we look forward to seeing you on 5 April 2014 in Westminster.
Best wishes
Tom Winnifrith
PS Remember there are now just 15 golden tickets left and that standard tickets are also selling fast. Some show give away tickets because they offer no value. UKInvestor is different. To book your ticket now go HERE
4189 days ago
Alliance Pharma (APH) is in the news today as it has announced an $11.5 million (£7.5 million) acquisition of all existing rights to the ‘Syntometrine’ drug from industry major Novartis
We can reveal that Nigel Wray – the man known as Britain’s Buffett – has on the back of this added to his material stake in the company. Wray argues
4226 days ago
This was in many ways my favourite part of UKInvestor Show 2013. Together with two good friends we chatted 100% without rehearsal on UK residential and commercial property, the death of the High street, the UK economy, Alliance Pharma, Domino's Pizza, share prices, Margaret Thatcher and much more. Leslau and Wray are always inspirational for me. And I had a ball.
4270 days ago
I think sound and vision nailed once again. I am finally getting the hang of this. I am meant to be celebrating St Patrick’s Day with some Irish-for-a-day folk which means just mindless drinking. Since they were not Irish yesterday they will not understand why there is nothing to celebrate today. And so I may dodge that for some more writing. Pro tem here is the video postcard for this week
On the Agenda
Approximate Running time 10 minutes
